Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.
Last feed update: Monday September 26th, 2016 07:43:54 PM
Kite immunotherapy drug helps blood cancer patients in study Monday September 26th, 2016 09:40:37 PM
(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of the news, rose 11 percent when trading resumed. Some 76 percent of patients taking the drug, called KTE-C19, showed significant tumor shrinkage, including 47 percent who ...
More U.S. babies born addicted to opiates like heroin Monday September 26th, 2016 09:40:13 PM
By Lisa Rapaport (Reuters Health) - The proportion of U.S. babies born suffering from withdrawal syndrome after exposure to heroin or prescription opiates in utero has more than doubled in less than a decade, a study suggests. Researchers focused on what’s known as neonatal abstinence syndrome, a condition akin to withdrawal that develops when babies essentially become addicted to drugs their mothers use during pregnancy. Nationally, the rate of neonatal abstinence syndrome involving mothers’ use of opiates ...
Walking is medicine? It helped high-risk seniors stay mobile Monday September 26th, 2016 09:08:26 PM
WASHINGTON (AP) — It's not too late to get moving: Simple physical activity — mostly walking — helped high-risk seniors stay mobile after disability-inducing ailments even if, at 70 and beyond, they'd long been couch potatoes.
Poor exercise habits may follow teens into adulthood Monday September 26th, 2016 08:08:31 PM
By Lisa Rapaport (Reuters Health) - Most American teenagers don’t get enough exercise, and they often stick with their sedentary ways as they enter adulthood, a U.S. study suggests. More than 9 in 10 adolescents fail to get the minimum 60 minutes of moderate to vigorous daily physical activity recommended by the U.S. Centers for Disease Control and Prevention (CDC), researchers report in the journal Pediatrics. “Physical inactivity is one of the major predictors of childhood and adolescent obesity, the consequences ...
Mylan faces scrutiny over EpiPen profit data shown to Congress Monday September 26th, 2016 07:39:41 PM
Mylan has been widely criticized for sharply raising the price of EpiPens, which are carried by people with life-threatening allergies. Mylan, which acquired the product in 2007, has raised the list price for a pair of EpiPens to $600 from about $100 in 2008. Lawmakers are trying to determine whether Mylan made more money on EpiPen than warranted from state Medicaid programs by having it classified as a generic product, resulting in much smaller rebates to the government health plans.
Nestle executive Cantarell quits after 40 years, sparking reshuffle Monday September 26th, 2016 07:27:10 PM
Luis Cantarell, who heads Nestle's Europe, Middle East and North Africa zone and has been an advocate of blurring the lines between food and pharmaceuticals, is stepping down after 40 years, the Swiss company said on Monday. Cantarell will be replaced in January by Marco Settembri, head of Nestle's water division, which will now be run by Maurizio Paternello, who moves from Nestle Russia and Eurasia, the company said in a statement.
Drugmaker Pfizer decides not to break up business Monday September 26th, 2016 07:12:11 PM
TRENTON, N.J. (AP) — Drug giant Pfizer says it won't split into two publicly traded companies, despite pressure from investors frustrated by its lagging stock price, ending years of Wall Street speculation over its strategy and future.
Clovis short sellers undaunted as stock price surges Monday September 26th, 2016 07:05:14 PM
By Lewis Krauskopf NEW YORK (Reuters) - Clovis Oncology Inc's share price has doubled in the past month, fueled by positive developments for the company's experimental cancer drug and takeover speculation. The biotech company said late last month its experimental ovarian cancer treatment would be reviewed on a priority basis, with U.S. regulators expected to rule on the drug, rucaparib, by Feb 23. Shares of Clovis, which has climbed to a market value of about $1.4 billion, rose steadily in the past month, from ...
Pfizer decides against split-up; more deals seen likely Monday September 26th, 2016 06:56:14 PM
Pfizer Inc , which was considering splitting itself for more than two years, said on Monday it would not do so, prompting shareholders to expect more deals that could bolster its roster of new medicines. The largest U.S. drugmaker said its lengthy analysis determined that splitting off its low-growth generics from its patent-protected branded products would not boost cash flow or better position the businesses competitively. "I never saw the logic behind a split-up," said portfolio manager Les Funtleyder ...
Why morning sickness may be a good thing Monday September 26th, 2016 05:30:50 PM
By Lisa Rapaport (Reuters Health) - For women with a history of miscarriage, experiencing nausea and vomiting during subsequent pregnancy attempts is linked to higher odds of success, a U.S. study suggests. “This study came from the long-standing idea that nausea and vomiting in pregnancy indicated that a woman was still pregnant,” said lead study author Stefanie Hinkle, a scientist at the National Institutes of Health in Bethesda, Maryland.
Feed aggregation powered by Syndicate Press.
Processed request in 0.21971 seconds.